HKB's NHP COPD Models provide pharmaceutical researchers with sophisticated platforms for investigating chronic obstructive pulmonary disease and emphysema. Our non-human primate models replicate the progressive airway obstruction, alveolar destruction, and chronic inflammation characteristic of COPD. Comprehensive endpoints include pulmonary function testing, CT imaging, and histopathological analysis.
HkeyBio is a China-based, globally-focused preclinical CRO dedicated exclusively to autoimmune and allergic diseases, with a unified service network across Asia, the Americas, Europe and Australia.
